|Awarded On||February 19, 2020|
|Title||Modulating the Gut- Tumor Microbial Axis to Reverse Pancreatic Cancer Immunosuooression|
|Award Mechanism||Individual Investigator Research Awards for Clinical Translation|
|Institution/Organization||The University of Texas M.D. Anderson Cancer Center|
|Principal Investigator/Program Director||Florencia McAllister|
*Pending contract negotiation
Pancreatic cancer is a lethal disease for which most therapies have very limited success. One of the main reasons for this is the presence of a strong immunosuppressive environment around the tumor. Not only the immune system is not recognizing and attacking the tumor but it is actually suppressing it. Therefore, strategies that can reverse immunosuppression into immune activation will be key to improve treatments outcomes. To learn how to improve outcomes we actually focused on learning what is different on tumors from patients that survived pancreatic cancer long-term vs typical tumors. We found that tumors from patients who survived the disease long-term have a much more activated immun...